Literature DB >> 28762332

Long Noncoding RNA NEAT1 Promotes Proliferation and Invasion via Targeting miR-181a-5p in Non-Small Cell Lung Cancer.

ShiDong Li1, JiaMei Yang2, Yubing Xia3, QingXia Fan1, Kun-Peng Yang4.   

Abstract

Long noncoding RNAs (lncRNAs) have been implicated in various biological processes and pathological conditions, including tumorigenesis. However, the exact roles of NEAT1 and its underlying mechanisms in non-small cell lung cancer (NSCLC) remain largely unclear. In the present study, lncRNA NEAT1 was detected to be significantly upregulated in NSCLC tissues and closely associated with advanced TNM stages, lymph node metastasis, distant metastasis, and poor prognosis. Further experiments revealed that lncRNA NEAT1 silencing inhibited cell proliferation and invasion in vitro. In addition, mechanistic analysis showed that lncRNA NEAT1 upregulated the miR-181a-5p-targeted gene HMGB2 through acting as a competitive "sponge" of miR-181a-5p. In conclusion, our study suggested that lncRNA NEAT1 plays an oncogenic role in NSCLC progression and provides potential mechanisms by which lncRNA NEAT1 contributes to this disease.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28762332     DOI: 10.3727/096504017X15009404458675

Source DB:  PubMed          Journal:  Oncol Res        ISSN: 0965-0407            Impact factor:   5.574


  34 in total

1.  LncRNA nuclear-enriched abundant transcript 1 regulates hypoxia-evoked apoptosis and autophagy via mediation of microRNA-181b.

Authors:  Ying Lv; Zhaoming Liu; Jiancheng Huang; Jie Yu; Yanbo Dong; Jun Wang
Journal:  Mol Cell Biochem       Date:  2019-12-18       Impact factor: 3.396

2.  LncRNA Neat1 Promotes Regeneration after Spinal Cord Injury by Targeting miR-29b.

Authors:  Guangtao Bai; Liang Jiang; Pingping Meng; Jiang Li; Chao Han; Yuyang Wang; Qiang Wang
Journal:  J Mol Neurosci       Date:  2020-11-11       Impact factor: 3.444

Review 3.  The Role of Long Non-coding RNA, Nuclear Enriched Abundant Transcript 1 (NEAT1) in Cancer and Other Pathologies.

Authors:  Miao Zhang; Jianmin Guo; Lifei Liu; Mei Huang; Yuexuan Li; Samuel Bennett; JiaKe Xu; Jun Zou
Journal:  Biochem Genet       Date:  2021-10-24       Impact factor: 1.890

4.  LncRNA NEAT1 Promotes the Malignant Progression of Colorectal Cancer by Targeting ZEB1 via miR-448.

Authors:  Hanquan Wu; Dengwen Dong; Jiwei Wang; Shiwen Yin; Yuanxiang Gong; Chao Yang; Yihan Bai; Junyi Wang; Yanhong Du
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

5.  Long non‑coding RNA HCG11 suppresses the malignant phenotype of non‑small cell lung cancer cells by targeting a miR‑875/SATB2 axis.

Authors:  Zhou Su; Mi Chen; Ruilin Ding; Lian Shui; Qingmei Zhao; Wenjuan Luo
Journal:  Mol Med Rep       Date:  2021-06-03       Impact factor: 2.952

6.  Identification and in vitro validation of diagnostic and prognostic biomarkers for lung squamous cell carcinoma.

Authors:  Xiaopeng Zhao; Chong Yuan; Xu He; Miao Wang; Haoran Zhang; Jingge Cheng; Hongyan Wang
Journal:  J Thorac Dis       Date:  2022-04       Impact factor: 2.895

7.  Neat1 in hematopoietic stem cells.

Authors:  Noam Fallik; Yael Bar-Lavan; Yariv Greenshpan; Oron Goldstein; Markus Grosch; Micha Drukker; Roi Gazit
Journal:  Oncotarget       Date:  2017-11-30

8.  Galectin-3 activates TLR4/NF-κB signaling to promote lung adenocarcinoma cell proliferation through activating lncRNA-NEAT1 expression.

Authors:  Wu Zhou; Xing Chen; Qinghua Hu; Xuliang Chen; Yingji Chen; Lingjin Huang
Journal:  BMC Cancer       Date:  2018-05-22       Impact factor: 4.430

9.  Five key lncRNAs considered as prognostic targets for predicting pancreatic ductal adenocarcinoma.

Authors:  Jukun Song; Qiuyan Xu; Haodeng Zhang; Xinhai Yin; Chen Zhu; Ke Zhao; Jianguo Zhu
Journal:  J Cell Biochem       Date:  2018-02-27       Impact factor: 4.429

10.  LncRNA NEAT1 enhances the radio-resistance of cervical cancer via miR-193b-3p/CCND1 axis.

Authors:  Dongmei Han; Jianfeng Wang; Guanghui Cheng
Journal:  Oncotarget       Date:  2017-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.